1. Bone RA, Landrum JT, Hime GW, Cains A, Zamor J. Stereochemistry of the human macular carotenoids. Invest Ophthalmol Vis Sci. 1993;34: 2033–2040.
2. Landrum JT, Bone RA. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys 2001; 385:28–40.
3. Krinsky NI, Landrum JT, Bone RA. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr. 2003;23: 171–201.
4. Krinsky NI, Johnson EJ. Carotenoid actions and their relation to health and disease. Mol Aspects Med. 2005;26:459–516.
5. Nolan JM, Power R, Stringham J, et al. Enrichment of macular pigment enhances con- trast sensitivity in subjects free of retinal disease: Central Retinal Enrichment Supplementation Trials - Report 1. Invest Ophthalmol Vis Sci. 2016;57:3429–3439.
6. Bone RA, Landrum JT, Fernandez L, Tarsis SL. Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Oph- thalmol Vis Sci. 1988;29:843–849.
7. Bernstein PS, Sharifzadeh M, Liu A, et al. Blue- light reflectance imaging of macular pigment in infants and children. Invest Ophthal Vis Sci. 2013; 54:4034–4040.
8. Sharifzadeh M, Bernstein PS, Gellermann W. Reflection-based imaging of macular pigment distributions in infants and children. J Biomed Opt. 2013;18:116001.
9. Caputo AR, Schnitzer RE, Lindquist TD, Sun S. Dilation in neonates: a protocol. Pediatrics. 1982; 69:77–80.
10. Takeuchi A, Nagata M, Terauchi H, et al. Multicenter prospective study of retinopathy of prematurity–II. Optimum timing of the first examination [article in Japanese]. J Jpn Ophthal- mol Soc. 1994;98:679–683.
11. Fierson WM. Screening examination of prema- ture infants for retinopathy of prematurity. Pediatrics. 2013;131:189–195.
12. Henriksen BS, Chan G, Hoffman RO, et al. Interrelationships between maternal carotenoid status and newborn infant macular pigment optical density and carotenoid status. Invest Ophthal Vis Sci. 2013;54:5568–5578.
13. Vinekar A, Mangalesh S, Jayadev C, Maldonado RS, Bauer N, Toth CA. Retinal imaging of infants on spectral domain optical coherence tomography. Biomed Res Int. 2015;2015:782420.
14. Vajzovic L, Hendrickson AE, O’Connell RV, et al. Maturation of the human fovea: correlation of spectral-domain optical coherence tomography findings with histology. Am J Ophthalmol. 2012; 154:779–789.
15. Hendrickson A, Possin D, Vajzovic L, Toth CA. Histologic development of the human fovea from midgestation to maturity. Am J Ophthalmol. 2012;154:767–778.
16. Berendschot TT, van Norren D. Objective determination of the macular pigment optical density using fundus reflectance spectroscopy. Arch Biochem Biophys. 2004;430:149–155.
17. Berendschot TT, van Norren D. Macular pig- ment shows ringlike structures. Invest Ophthalmol Vis Sci. 2006;47:709–714.
18. Delori FC, Goger DG, Keilhauer C, Salvetti P, Staurenghi G. Bimodal spatial distribution of macular pigment: evidence of a gender relation- ship. J Opt Soc Am A Opt Image Sci Vis. 2006;23: 521–538.
19. Manzoni P, Guardione R, Bonetti P, et al. Lutein and zeaxanthin supplementation in preterm very low-birth-weight neonates in neonatal intensive care units: a multicenter randomized controlled trial. Am J Perinatol. 2013;30:25–32.
20. Dani C, Lori I, Favelli F, et al. Lutein and zeaxanthin supplementation in preterm infants to prevent retinopathy of prematurity: a randomized controlled study. J Matern Fetal Neonatal Med. 2012;25:523–527.
21. Romagnoli C, Giannantonio C, Cota F, et al. A prospective, randomized, double blind study comparing lutein to placebo for reducing occur- rence and severity of retinopathy of prematurity. J Matern Fetal Neonatal Med. 2011;24(Suppl 1): 147–150.
22. Maldonado RS, O’Connell RV, Sarin N, et al. Dynamics of human foveal development after premature birth. Ophthalmology. 2011;118:2315– 2325.
23. Lee AC, Maldonado RS, Sarin N, et al. Macular features from spectral-domain optical coherence tomography as an adjunct to indirect ophthal- moscopy in retinopathy of prematurity. Retina. 2011;31:1470–1482.
24. Vinekar A, Avadhani K, Sivakumar M, et al. Understanding clinically undetected macular changes in early retinopathy of prematurity on spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2011;52:5183–5188.